The Penicillin Market is being driven by Rising prevalence of infectious diseases
The Penicillin Market is expected to grow at a CAGR of 5.4% during 2023 and 2028. During this period, the market is also expected to show a growth of USD 2.82 billion. In the Penicillin Market, strategic alliances through licensing and collaborative agreements play a pivotal role in the co-development and commercialization of drugs across various geographies. Such partnerships enable the leveraging of each company's unique technical expertise, regulatory experience, and development capabilities. Co-development agreements facilitate the sharing of resources, risks, and costs, ensuring adequate funding and reducing liability for individual companies in case of failures. Mergers and acquisitions (M&A) are also common practices to expand market reach or bolster product portfolios, thereby attracting more venture investments and enhancing the competitive edge in the Penicillin Market.
Get more information on Penicillin Market by requesting a sample report
The market is segmented based on
According to Technavio, There are several factors that are causing the market to flourish during the forecast period, which are as follows:
However, the market also witnesses some limitations, which are as follows:
Rich Experience: 20+ years leading global market research, trusted insights across industries.
Unlock Business Potential with Technavio: Maximize ROI with Technavio's tailored market research: deep dives and actionable insights.
Your Guide to Market Success: Empower your business with Technavio's market research and future-proof your decisions.
Market Scope |
|
Report Coverage |
Details |
Page number |
165 |
Base year |
2023 |
Historic period |
2018-2022 |
Forecast period |
2024-2028 |
Growth momentum & CAGR |
Accelerate at a CAGR of 5.4% |
Market growth 2024-2028 |
USD 2.82 billion |
Market structure |
fragmentation |
YoY growth 2023-2024(%) |
4.72 |
Key countries |
US, Canada, UK, Germany, and China |
Competitive landscape |
Leading Companies, Market Positioning of Companies, Competitive Strategies, and Industry Risks |
Find out which segment is leading the market by accessing the free PDF report
Penicillin is a broad-spectrum antibiotic that has been widely used to treat various bacterial infections, including respiratory tract infections like pneumonia and bacterial infections caused by Neisseria meningitidis, Staphylococcus aureus, Streptococcus pyogenes, and Streptococcus pneumoniae. Two main types of penicillin are available in the market: broad-spectrum penicillin and narrow-spectrum penicillin. Broad-spectrum penicillin, such as ampicillin and amoxicillin, have a wider range of activity against different types of bacteria. In contrast, narrow-spectrum penicillin, like natural penicillin, is effective against specific bacterial strains. Penicillin is derived from natural sources, such as Penicillium chrysogenum, and is also produced synthetically as semisynthetic penicillin. Penicillinase-resistant penicillin, such as amoxicillin, is produced by modifying the natural penicillin structure to resist penicillinase enzymes produced by some bacteria. The penicillin market includes finished products and raw materials. Travel restrictions and lockdowns due to the COVID-19 pandemic have disrupted global supply chains, leading to shortages of raw materials and finished penicillin products. This has resulted in increased demand for generic penicillin medication, with many patients turning to brand-name counterparts due to their reliability and consistency. R&D efforts are ongoing to develop new penicillin derivatives to combat antimicrobial resistance (AMR). The global penicillin market is expected to grow significantly due to the increasing prevalence of bacterial infections and the need for effective and affordable antibiotics. Penicillin is available in various forms, including injections, capsules, and tablets.
According to Technavio, the global penicillin market is a segment of the expansive global pharmaceuticals industry, encompassing entities involved in research and development (R&D) or manufacturing of various pharmaceutical offerings, including generic and non-generic drugs, veterinary drugs, and penicillin. The global healthcare industry, which includes the pharmaceuticals sector, is projected to expand based on several key drivers. Notably, the aging population is a significant factor, with the number of individuals above 60 years anticipated to rise substantially.. Industries are leveraging the products belonging to the market for customer engagement, transactional notifications, and promotional offers.
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/
Safe and Secure SSL Encrypted